Skip to main content
Clinical Trials/NCT03799757
NCT03799757
Completed
Phase 4

Role of Wound Installation With Bupivacaine Through Surgical Drains in Postoperative Analgesia in Modified Radical Mastectomy

Alexandria University1 site in 1 country168 target enrollmentJanuary 2016

Overview

Phase
Phase 4
Intervention
40ml of 0.25% bupivacaine
Conditions
Pain, Postoperative
Sponsor
Alexandria University
Enrollment
168
Locations
1
Primary Endpoint
Visual analogue pain score
Status
Completed
Last Updated
7 years ago

Overview

Brief Summary

in this study we are investigating the role of instillation of Bupivacaine through surgical drains at the end of mastectomy surgeries in controlling post operative pain and decreasing their pain killers requirement in the early postoperative period

Detailed Description

patients were enrolled into 2 groups. in one group the wound was installed by 40ml of 0.25% bupivacaine through axillary and chest wall drains (20ml in each drain). Then, the drains were clamped for 20 minutes. in the other group the wound was installed by 40ml of 0.9% normal saline through axillary and chest wall drains (20ml in each drain). Then, the drains were clamped for 20 minutes. (placebo group) patients and health care providers were blinded as regard the study group patients enrolled in. Visual Analog Pain Scale which is a score for detection of how much the patient is annoyed from the pain- was assessed two and four hours post-operative then every four hours thereafter.

Registry
clinicaltrials.gov
Start Date
January 2016
End Date
December 2018
Last Updated
7 years ago
Study Type
Interventional
Study Design
Parallel
Sex
Female

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Mahmoud A. Alhussini

lecturer surgical oncology

Alexandria University

Eligibility Criteria

Inclusion Criteria

  • female patients with unilateral breast cancer candidates for total mastectomy and axillary dissection

Exclusion Criteria

  • Male patients
  • Bilateral breast cancer.
  • Patients with a history of a long duration of NSAID intake or other painkillers, drug abuse
  • Patients with chest wall pain like Tietze syndrome, history of angina pectoris or recent HZV infection.
  • Patients with known psychological or mental problems.
  • Patients who were not exposed to axillary dissection

Arms & Interventions

Bupivacaine

The wound was installed by 40ml of 0.25% bupivacaine through axillary and chest wall drains (20ml in each drain). Then, the drains were clamped for 20 minutes.

Intervention: 40ml of 0.25% bupivacaine

Placebo

The wound was installed by 40ml of 0.9% normal saline through axillary and chest wall drains (20ml in each drain). Then, the drains were clamped for 20 minutes. (placebo group)

Intervention: 40ml of 0.9% normal saline

Outcomes

Primary Outcomes

Visual analogue pain score

Time Frame: first 24 hours

The intensity of pain will be assessed by the VAS score

Number of demands for analgesic

Time Frame: First 24 hours

How many times the patient will require analgesics

Timing of first demand for analgesic

Time Frame: First 24 hours

Time lapse between recovery from surgery and first demand for analgesic

Study Sites (1)

Loading locations...

Similar Trials